Medtronic plc
MDT · NYSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $108,967,456 | $106,534,648 | $120,586,264 | $140,092,864 |
| - Cash | $2,218,000 | $1,284,000 | $1,543,000 | $3,714,000 |
| + Debt | $28,516,000 | $25,024,000 | $24,364,000 | $24,114,000 |
| Enterprise Value | $135,265,456 | $130,274,648 | $143,407,264 | $160,492,864 |
| Revenue | $33,537,000 | $32,364,000 | $31,227,000 | $31,686,000 |
| % Growth | 3.6% | 3.6% | -1.4% | – |
| Gross Profit | $21,905,000 | $21,148,000 | $20,508,000 | $21,541,000 |
| % Margin | 65.3% | 65.3% | 65.7% | 68% |
| EBITDA | $9,218,000 | $8,203,000 | $8,697,000 | $8,777,000 |
| % Margin | 27.5% | 25.3% | 27.9% | 27.7% |
| Net Income | $4,662,000 | $3,676,000 | $3,758,000 | $5,039,000 |
| % Margin | 13.9% | 11.4% | 12% | 15.9% |
| EPS Diluted | 3.61 | 2.76 | 2.82 | 3.73 |
| % Growth | 30.8% | -2.1% | -24.4% | – |
| Operating Cash Flow | $7,044,000 | $6,787,000 | $6,039,000 | $7,346,000 |
| Capital Expenditures | -$1,859,000 | -$1,587,000 | -$1,459,000 | -$1,368,000 |
| Free Cash Flow | $5,185,000 | $5,200,000 | $4,580,000 | $5,978,000 |